Atlas Pharmaceuticals Overview

  • Founded
  • 2017
  • Status
  • Acquired/​Merged
  • Employees
  • 9
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Atlas Pharmaceuticals General Information


Developer of sterile, non-sterile, controlled, and non-controlled medications for humans and animals. The company's medications include lidocaine, sodium chloride, atropine, acetylcysteine, buprenorphine, doxycycline, and other related products, which are crafted using bioburden, sterility, endotoxin, potency, preservative effectiveness, and particulate monitoring processes.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
  • 711 East Carefree Highway
  • Suite 207
  • Phoenix, AZ 85085
  • United States
+1 (623) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Atlas Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Atlas Pharmaceuticals‘s full profile, request access.

Request a free trial

Atlas Pharmaceuticals Executive Team (2)

Name Title Board Seat Contact Info
Robert Eaton President & Chief Executive Officer
Nancy Costlow Director
To view Atlas Pharmaceuticals’s complete executive team members history, request access »

Atlas Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial